Hindus rated “fairly warmly” in USA, survey reveals

Most religious groups in USA rate Hindus fairly warmly, according to “polling and analysis” posted by Washington DC headquartered Pew Research Center, a nonpartisan fact tank, on February 15.

Asked to rate a variety of groups on a “feeling thermometer” ranging from 0 to 100, Americans’ feelings toward Hindus have shifted from relatively neutral place of 50 in 2014 on the thermometer to somewhat warmer rating of 58.

Americans aged 18-29 put the Hindus at 64 on the thermometer, which is higher than Jews, Atheists, Evangelical Christians, Mainline Protestants, Muslims and Mormons. Jews gave Hindus a thermometer rating of 70, which is highest given to Hindus by any religious group.

Hindus were rated at 70 by those who had personal connections with someone in the Hindu community, as compared to 54 given by those who had no such connection.

But only 22% of Americans say they personally know a Hindu.

These were among the findings of a new Pew Research Center survey of 4,248 adults conducted between January nine to 23 on the Center’s nationally representative American Trends Panel.

Meanwhile Hindu statesman Rajan Zed, in a statement in Nevada today, congratulating the American Hindu community on climbing higher on the warmth scale; urged them to continue with the traditional values of hard work, higher morals, stress on education, sanctity of marriage, etc.; amidst so many distractions.

Rajan Zed, who is President of Universal Society of Hinduism, advised Hindus to focus on inner search, stay pure, explore the vast wisdom of scriptures, make spirituality more attractive to youth and children, stay away from the greed, and always keep God in the life.

There are about three million Hindus in USA.

Mr. K. T. Rama Rao Lays Foundation for BE’s Vaccine SEZ Plant

Hyderabad, India – February 6, 2017: Mr. K. T. Rama Rao, Honourable Minister for Industries & Commerce, IT, Municipal Administration & Urban Development, unveiled the foundation for a new vaccines plant being constructed by Biological E. Limited (BE) in the Special Economic Zone (SEZ) at Genome Valley in Kolthur Village, located on the outskirts of Hyderabad. The Minister was accompanied by Dr. Paul Stoffels, Worldwide Chairman, Pharmaceuticals, Johnson & Johnson (J&J), Ms. Mahima Datla, Managing Director, BE, Mr. Jayesh Ranjan, IT Secretary, Soumya Swaminathan, Director-general, Indian Council of Medical Research, and Mr. M. Sudheer Reddy, Medchal MLA, at the inaugural event of laying the foundation.

Addressing the gathering on this occasion, the Minister appreciated the expansion efforts of Biological E. Limited in being aligned with the State Government’s vision of industrial expansion, creation of employment and the commitment to make Hyderabad an industrial hub in India and thus realise the dream of the honourable Chief Minister, K. Chandrashekar Rao – the creation of Bangaru (/Golden) Telangana. He fondly recalled that BE, as one of the foremost Pharmaceutical & Biologics Companies in India, being based out of the State of Telangana, in addition to substantial exports of vaccines, contributes significantly to the Universal Immunization Programme launched by the Government of India.

Welcoming the gathering, Ms. Mahima Datla, Managing Director, BE, thanked the Honourable Minister and Dr. Stoffels, for laying the foundation for the new vaccines plant at the recently approved SEZ. The MD also appreciated the efforts of the Government of Telangana in general and Mr. K T Rama Rao in particular for helping the investors and entrepreneurs in setting up new ventures and industries and creating a conducive environment for smooth execution of business operations.

Elaborating further about the plant, Ms. Mahima said that BE is planning an initial investment of up to Rs.300 crore in this new plant, which would help the existing vaccines plant augment the production and manufacture new products that are in the pipeline. This investment is in line with and part of the already earmarked overall outlay of Rs.1000 crore in the Genome Valley across BE’s Vaccines & Pharma businesses that are underway. The construction of this new SEZ vaccines plant on about 29 acres of land would be completed by April 2018 and commercial production is expected to begin by December 2019. Ms. Mahima also said that by the time BE’s expansion initiatives in the Genome Valley are completed, an additional employment opportunity for around 1000 people would be generated.

About Biological E. Limited

Biological E. Limited (BE), founded in 1953, the first private sector biological products company in India and the first pharmaceutical company in South India. Originally incorporated as Biological Products Private Limited, BE is a globally recognized vaccine manufacturer and has supplied over two billion doses of vaccines till date all over the world.

BE supplies several essential and lifesaving Vaccines and Pharmaceuticals to UN Agencies viz. UNICEF, PAHO and several global markets, and in India to the National Immunization Programme, various State Governments, PSUs, Indian Armed Forces and the domestic retail market. With a mission to improve health & survival of people, BE serves by providing equitable access to quality vaccines and therapeutics. BE has a long and richly textured history of supporting public health programmes in India for over five decades. BE’s portfolio of WHO pre-qualified vaccines include the 5-in-1 Pentavalent and a Japanese Encephalitis vaccine and its future offerings promise to be even more exciting.